<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Pregestational diabetes mellitus.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;American College of Obstetricians and Gynecologists (ACOG). Pregestational diabetes mellitus. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2005 Mar. 11 p.&amp;nbsp;(ACOG practice bulletin; no. 60).&amp;nbsp; [86 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The American College of Obstetricians and Gynecologists (ACOG) reaffirmed the currency of the guideline in 2010.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="ICD9CM: Diabetes mellitus of mother, complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication  (648.03); Diabetes mellitus of mother, complicating pregnancy, childbirth, or the puerperium, unspecified as to episode of care or not applicable  (648.00); Electrocardiogram  (89.52)"/><FieldValue Value="MSH: Blood Chemical Analysis ; Blood Glucose ; Blood Glucose Self-Monitoring ; Breast Feeding ; Cesarean Section ; Contraception ; Counseling ; Delivery, Obstetric ; Diabetic Diet ; Diabetic Ketoacidosis ; Education ; Electrocardiography ; Fetal Monitoring ; Folic Acid ; Hemoglobin A, Glycosylated ; Hypoglycemic Agents ; Insulin ; Labor, Induced ; Preconception Care ; Pregnancy in Diabetics ; Pregnancy Outcome ; Retinoscopy ; Self Care ; Thyroid Function Tests ; Urinalysis ; Vitamins "/><FieldValue Value="MTH: Blood Chemical Analysis ; Blood Glucose ; Blood glucose measurement ; Breast Feeding ; Cesarean section ; Contraception care education ; Contraceptive methods ; Counseling ; Diabetic Diet ; Diabetic Ketoacidosis ; Electrocardiography ; Fetal Monitoring ; Folic Acid ; Glycosylated hemoglobin A ; Hemoglobin A1c measurement ; Induction of labor procedure ; Insulin ; Knowledge acquisition ; Obstetric Delivery ; Pregnancy in Diabetics ; Retinoscopy ; Self-care interventions ; Thyroid Function Tests ; urinalysis ; Urine ketone test ; Vitamins "/><FieldValue Value="PDQ: folic acid ; insulin "/><FieldValue Value="SNOMEDCT_US: Blood chemistry  (166312007); Breast fed  (169741004); Cesarean section  (11466000); Contraception  (13197004); Contraception care education  (408968008); Counseling  (129441002); Counseling  (409063005); Delivery - action  (236973005); Delivery - action  (360149000); Diabetes mellitus in mother complicating pregnancy, childbirth AND/OR puerperium  (199223000); Diabetes mellitus in mother complicating pregnancy, childbirth AND/OR puerperium  (76751001); Diabetic diet  (160670007); Diabetic ketoacidosis  (420422005); Electrocardiographic procedure  (29303009); Family education  (311403008); Family education  (460616007); Folic acid  (6247001); Folic acid  (63718003); Glucose measurement, blood  (33747003); Glycosylated hemoglobin A  (33601001); Hemoglobin A1c measurement  (43396009); Hypoglycemic agent  (312064005); Hypoglycemic agent  (373299009); Induction of labor  (236958009); Insulin  (39487003); Insulin  (412222002); Insulin  (67866001); Preconception care  (429070000); Retinoscopy  (397524001); Self-care interventions  (384758001); Self-monitoring of blood glucose  (308113006); Thyroid panel  (35650009); Urinalysis  (167217005); Urinalysis  (27171005); Urine ketone test  (167285005); Vitamin  (12968008); Vitamin  (87708000)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Pregestational diabetes mellitus&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Management" /><FieldValue Value="Treatment" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Endocrinology" /><FieldValue Value="Family Practice" /><FieldValue Value="Internal Medicine" /><FieldValue Value="Obstetrics and Gynecology" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Physicians" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;ul type=&quot;disc&quot;&gt;&#xD;&#xA;&lt;li&gt;To aid practitioners in making decisions about appropriate obstetric and gynecologic care&lt;/li&gt;&#xD;&#xA;&lt;li&gt;To provide an overview of the current understanding of pregestational diabetes mellitus and to suggest management guidelines during pregnancy&lt;/li&gt;&lt;/ul&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Pregnant women with diabetes mellitus&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Management/Counseling&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;ol start=&quot;1&quot; type=&quot;1&quot;&gt;&#xD;&#xA;&lt;li&gt;Dietary regulation&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Blood glucose and urine ketone self-monitoring&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Hemoglobin A&lt;sub&gt;1c&lt;/sub&gt; levels&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Family training to respond to potential hypoglycemic episodes&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Preconceptional counseling&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Preconceptional retinal examination, 24-hour urine collection, electrocardiography, thyroid function study&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Assessment of diabetic ketoacidosis &lt;/li&gt;&#xD;&#xA;&lt;li&gt;Antepartum fetal monitoring (ultrasound, echocardiography, fetal movement counting, nonstress test, biophysical profile, contraction stress test, umbilical artery Doppler velocimetry, amniocentesis)&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Blood glucose monitoring during labor and delivery&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Encouragement of breastfeeding&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Counseling on postpartum contraception options&lt;/li&gt;&lt;/ol&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Treatment&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;ol start=&quot;1&quot; type=&quot;1&quot;&gt;&#xD;&#xA;&lt;li&gt;Insulin injections or continuous subcutaneous infusion&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Limited use of oral hypoglycemic agents&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Treatment of diabetic ketoacidosis&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Cesarean delivery&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Timing of delivery&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Induction of labor (not recommended with suspected fetal macrosomia)&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Multivitamin with folic acid&lt;/li&gt;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul type=&quot;disc&quot;&gt;&#xD;&#xA;&lt;li&gt;Blood glucose levels&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Incidence of maternal morbidity (diabetes-related retinopathy, neuropathy, nephropathy, hypertension, ketoacidosis, uteroplacental insufficiency)&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Incidence of perinatal morbidity or mortality&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Incidence of obstetric complications (preterm labor, hydramnios, preeclampsia, fetal intrauterine growth restriction, primary cesarean delivery)&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Cesarean delivery rate&lt;/li&gt;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Hand-searches of Published Literature (Primary Sources)" /><FieldValue Value="Hand-searches of Published Literature (Secondary Sources)" /><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The MEDLINE database, the Cochrane Library, and the American College of Obstetricians and Gynecologists' own internal resources and documents were used to conduct a literature search to locate relevant articles published between January 1985 and October 2004. The search was restricted to articles published in the English language. Priority was given to articles reporting results of original research, although review articles and commentaries also were consulted. Abstracts of research presented at symposia and scientific conferences were not considered adequate for inclusion in this document. Guidelines published by organizations or institutions such as the National Institutes of Health and the American College of Obstetricians and Gynecologists were reviewed, and additional studies were located by reviewing bibliographies of identified articles.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;2010 Reaffirmation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For reaffirmation of a current Practice Bulletin, MEDLINE and Cochrane are searched for new literature. At the discretion of the review committee, additional databases may be searched for particular topics as warranted. In addition, committee members identify relevant literature for review.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Studies were reviewed and evaluated for quality according to the method outlined by the U.S. Preventive Services Task Force:&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;I&lt;/strong&gt;: Evidence obtained from at least one properly designed randomized controlled trial.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;II-1&lt;/strong&gt;: Evidence obtained from well-designed controlled trials without randomization.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;II-2&lt;/strong&gt;: Evidence obtained from well-designed cohort or case&amp;#8211;control analytic studies, preferably from more than one center or research group.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;II-3&lt;/strong&gt;: Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments also could be regarded as this type of evidence.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;III&lt;/strong&gt;: Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Systematic Review" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Analysis of available evidence was given priority in formulating recommendations. When reliable research was not available, expert opinions from obstetrician&amp;ndash;gynecologists were used. See also the &quot;Rating Scheme for the Strength of Recommendations&quot; field regarding Grade C recommendations.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;2010 Reaffirmation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Each American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin is reviewed every 18&amp;ndash;24 months by a member of the Practice Bulletins Committee. The reviewer presents the practice bulletin and any new literature at a full committee hearing. The committee then reaches a consensus on whether to reaffirm or withdraw the practice bulletin.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Based on the highest level of evidence found in the data, recommendations are provided and graded according to the following categories:&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Level A&lt;/strong&gt; &amp;#8212; Recommendations are based on good and consistent scientific evidence.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Level B&lt;/strong&gt; &amp;#8212; Recommendations are based on limited or inconsistent scientific evidence.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Level C&lt;/strong&gt; &amp;#8212; Recommendations are based primarily on consensus and expert opinion.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="Internal Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Practice Bulletins are validated by two internal clinical review panels composed of practicing obstetrician-gynecologists generalists and sub-specialists. The final guidelines are also reviewed and approved by the American College of Obstetricians and Gynecologists (ACOG) Executive Board.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The grades of evidence (I-III) and levels of recommendation (A-C) are defined at the end of the &amp;quot;Major Recommendations&amp;quot; field.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;The following recommendations are based on limited or inconsistent scientific evidence (Level B)&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;ul type=&quot;disc&quot;&gt;&#xD;&#xA;&lt;li&gt;Suspected fetal macrosomia is not an indication for induction of labor because induction does not improve maternal or fetal outcomes.&lt;/li&gt;&#xD;&#xA;&#xD;&#xA;&lt;li&gt;Antepartum fetal monitoring, including fetal movement counting, the nonstress test, the biophysical profile, and the contraction stress test when performed at appropriate intervals, is a valuable approach and can be used to monitor the pregnancies of women with pregestational diabetes mellitus.&lt;/li&gt;&#xD;&#xA;&#xD;&#xA;&lt;li&gt;Adequate maternal glucose control should be maintained near physiologic levels before conception and throughout pregnancy to decrease the likelihood of spontaneous abortion, fetal malformation, fetal macrosomia, intrauterine fetal death, and neonatal morbidity.&lt;/li&gt;&#xD;&#xA;&#xD;&#xA;&lt;li&gt;Patients and their families should be taught how to respond quickly and appropriately to hypoglycemia.&lt;/li&gt;&#xD;&#xA;&#xD;&#xA;&lt;li&gt;Preconceptional counseling for women with pregestational diabetes mellitus has been reported to be beneficial and cost-effective and should be encouraged.&lt;/li&gt;&#xD;&#xA;&#xD;&#xA;&lt;li&gt;The use of oral agents for control of type 2 diabetes mellitus during pregnancy should be limited and individualized until data regarding the safety and efficacy of these drugs become available.&lt;/li&gt;&#xD;&#xA;&#xD;&#xA;&lt;li&gt;To prevent traumatic birth injury, cesarean delivery may be considered if the estimated fetal weight is greater than 4,500 g in women with diabetes.&lt;/li&gt;&lt;/ul&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;u&gt;Definitions&lt;/u&gt;&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Grades of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;I&lt;/strong&gt;: Evidence obtained from at least one properly designed randomized controlled trial.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;II-1&lt;/strong&gt;: Evidence obtained from well-designed controlled trials without randomization.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;II-2&lt;/strong&gt;: Evidence obtained from well-designed cohort or case&amp;#8211;control analytic studies, preferably from more than one center or research group.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;II-3&lt;/strong&gt;: Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments also could be regarded as this type of evidence.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;III&lt;/strong&gt;: Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Levels of Recommendations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Level A&lt;/strong&gt; &amp;#8212; Recommendations are based on good and consistent scientific evidence.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Level B&lt;/strong&gt; &amp;#8212; Recommendations are based on limited or inconsistent scientific evidence.&lt;/p&gt;&#xD;&#xA;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Level C&lt;/strong&gt; &amp;#8212; Recommendations are based primarily on consensus and expert opinion.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None provided&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of supporting evidence is identified and graded for each recommendation (see &amp;quot;Major Recommendations&amp;quot;).&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Appropriate management of pregestational diabetes mellitus&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;ul type=&quot;disc&quot;&gt;&#xD;&#xA;&lt;li&gt;Major disadvantages of insulin pump use include the increased cost of the pump and pump supplies. In addition, if the delivery of insulin is interrupted or impaired by battery failure or infection at the infusion site, diabetic ketoacidosis may develop rapidly.&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Metformin is a category B drug, and although there are more reports of its use during pregnancy, the long-term effects of in utero exposure have not been well studied. The use of all oral agents for control of type 2 diabetes mellitus during pregnancy should be limited and individualized until data regarding the safety and efficacy of these drugs become available.&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Because hypoglycemia and hypokalemia are frequent complications of diabetic ketoacidosis therapy, glucose and potassium concentrations should be monitored closely. Although maternal mortality is rare, fetal mortality has ranged from 35% of cases to, more recently, 10% of cases.&lt;/li&gt;&lt;/ul&gt;" /></Field></Section><Section SecID="430" OrdBy="800" Name="Contraindications"><Field FieldID="144" OrdBy="805" ID="431" Name="Contraindications" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers should be discontinued before conception and should not be used during pregnancy because of their adverse fetal effects.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;These guidelines should not be construed as dictating an exclusive course of treatment or procedure. Variations in practice may be warranted based on the needs of the individual patient, resources, and limitations unique to the institution or type of practice.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;An implementation strategy was not provided.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Foreign Language Translations" /><FieldValue Value="Patient Resources" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Living with Illness" /><FieldValue Value="Staying Healthy" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;American College of Obstetricians and Gynecologists (ACOG). Pregestational diabetes mellitus. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2005 Mar. 11 p.&amp;nbsp;(ACOG practice bulletin; no. 60).&amp;nbsp; [86 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2005 Mar (reaffirmed 2010)" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="American College of Obstetricians and Gynecologists - Medical Specialty Society" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;American College of Obstetricians and Gynecologists (ACOG)&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins-Obstetrics&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The American College of Obstetricians and Gynecologists (ACOG) reaffirmed the currency of the guideline in 2010.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: None available&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Print copies: Available for purchase from the American College of Obstetricians and Gynecologists (ACOG) Distribution Center, PO Box 933104, Atlanta, GA 31193-3104; telephone, 800-762-2264, ext. 192; e-mail: &lt;a href=&quot;mailto:sales@acog.org&quot;&gt;sales@acog.org&lt;/a&gt;. The ACOG Bookstore is available online at the &lt;a href=&quot;http://www.acog.org/bookstore/&quot; title=&quot;ACOG Web site&quot; target=&quot;_blank&quot;&gt;ACOG Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None available&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following is available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Diabetes and pregnancy. Atlanta (GA): American College of Obstetricians and Gynecologists (ACOG); 2005.&lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Electronic copies: Available from the &lt;a href=&quot;http://www.acog.org/publications/patient_education/bp051.cfm&quot; title=&quot;ACOG Web site&quot; target=&quot;_blank&quot;&gt;American College of Obstetricians and Gynecologists (ACOG) Web site&lt;/a&gt;. Copies are also available in Spanish.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Print copies: Available for purchase from the American College of Obstetricians and Gynecologists (ACOG) Distribution Center, PO Box 933104, Atlanta, GA 31193-3104; telephone, 800-762-2264, ext. 192; e-mail: &lt;a href=&quot;mailto:sales@acog.org&quot;&gt;sales@acog.org&lt;/a&gt;. The ACOG Bookstore is available online at the &lt;a href=&quot;http://www.acog.org/bookstore/&quot; title=&quot;ACOG Web site&quot; target=&quot;_blank&quot;&gt;ACOG Web site&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Disclaimer&quot;&gt;Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI Institute on October 10, 2007. The information was verified by the guideline developer on December 3, 2007. The information was reaffirmed by the guideline developer in 2010 and updated by ECRI Institute on December 17, 2010.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
